Selank is a synthetic peptide studied for anxiety and claimed to reduce it without heavy sedation.
What Selank does and why that matters
Selank is a synthetic seven-amino-acid peptide studied as an anxiety treatment. The intended real-life effect is to make anxious thoughts and physical tension easier to manage without the heavy sedation associated with some anxiety medicines. The cited study compared Selank with medazepam, not placebo, and does not establish a confirmed brain mechanism or show how reliably people would feel better. [1,2]
Function evidence: Small anxiety study; practical benefit and mechanism uncertain
What people hope to notice
The hoped-for change is concrete: fewer anxious thoughts, less physical tension and better ability to work, sleep or socialize, without feeling heavily sedated. The often-cited study compared Selank with medazepam and did not include a placebo group. Its limited reporting does not tell us how much improvement came from Selank, how many people would respond, how quickly a change would be noticeable or whether it performs better than established care. It supports continued study, but not precise promises about calm, focus or onset. [1,2]
What supports this description: Active-comparator study without placebo; effect size and reliability unclear
Selank Dosing status
Dose: No consumer dose is established or recommended here. | Frequency: No routine treatment schedule established. | Cycle: No validated consumer cycle. | Route: No routine patient route established.
Preparation: No patient reconstitution recipe. Trial preparation is not a recommendation..
Selank is an experimental synthetic peptide. The often-cited anxiety study included 62 people: 30 received Selank and 32 received medazepam. There was no placebo group. The abstract gives broad comparative findings but does not include the symptom percentages or effect sizes that the site previously reported. [1,2]
Selank Effects
Anxiety study. The study compared Selank with medazepam in adults with anxiety disorders. Without a placebo group and with limited reporting in the abstract, it cannot support precise claims about response rates, onset, or superiority. [1]
Selank Side Effects
Safety and product uncertainty. The small study does not establish long-term safety, broad psychiatric effectiveness, or a consumer dosing plan. FDA also identifies immunogenicity and impurity concerns for compounded Selank. [2]
Frequently Asked Questions About Selank
Was Selank compared with placebo?
No. The cited study assigned 30 participants to Selank and 32 to medazepam. [1]
Does the study report the detailed percentages once shown here?
No. The PubMed abstract does not report those detailed effect sizes, so they have been removed. [1]
Evidence
Small active-comparator study; no FDA approval. Selank is an experimental synthetic peptide. The often-cited anxiety study included 62 people: 30 received Selank and 32 received medazepam. There was no placebo group. The abstract gives broad comparative findings but does not include the symptom percentages or effect sizes that the site previously reported. [1,2]
Medvedev VE, et al. Optimization of the treatment of anxiety disorders with Selank Zh Nevrol Psikhiatr Im S S Korsakova, 2008. PMID 18454096
U.S. Food and Drug Administration Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks: Selank , . Source
Storage
Educational evidence summary. Approval applies only to the named product and indication; compounded, investigational, and research-market products are different categories.
◇An FDA-approved label or a patient-specific prescription from a licensed pharmacy
◇The active ingredient, strength, dosage form, concentration, lot, and dispensing instructions
◇Identity or purity tests only support the tests performed; they do not prove sterility, endotoxin safety, dose accuracy, stability, or clinical suitability
◇A “research use only” vial is not a patient medicine
